ABBOTT PARK, Ill., Nov. 6, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that a team of its scientists identified a new subtype of the human immunodeficiency virus (HIV), called HIV-1 Group M, subtype L.1 The findings, published today in the

CARY, N.C., Nov. 6, 2019 /PRNewswire/ -- Upcoming changes to Medicare reimbursement requirements are altering accreditation rules for all home infusion therapy suppliers. Accreditation Commission for Health Care (ACHC) has launched a new Home Infusion Therapy Accreditation program to assist providers in addressing the challenges these changes present to healthcare organi

HOLLYWOOD, Calif., Nov. 6, 2019 /PRNewswire/ -- Ed Asner, seven-time Emmy®-winning actor affectionately known as Lou Grant and UP's Carl Fredricksen, is turning 90 years old and Hollywood came out to roast and celebrate this special milestone. Highly acclaimed artists

TORONTO, Nov. 6, 2019 /PRNewswire/ -- International Medical Solutions ("IMS") and Eastern Health have signed an agreement to optimize peer learning for Medical

RANCHO CORDOVA, Calif., Nov. 6, 2019 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing for regenerative medicine, today announced that the Company will release its financial results for the third quarter ended September 30, 2019 and provide a strategic corporate update on

HOLON, Israel, Nov. 6, 2019 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and leader in predictive target discovery, announced today that The European Patent Office (EPO) has granted a new patent covering the composition of matter and use of COM902, its im

ISFIYA, Israel, Nov. 6, 2019 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of the C-Scan® System, the first and only preparation-free ingestible

SAN DIEGO, Nov. 6, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) presented new data evaluating the human mass balance, metabolic disposition, and pharmacokin

CHARLOTTE, N.C., Nov. 6, 2019 /PRNewswire/ -- cbdMD, Inc., a nationally recognized consumer cannabidiol (CBD) brand (NYSE American: YCBD), is excited to announce that they have become the Official CBD Partner, and the first CBD sponsor, of Skatepark of Tampa (SPoT).

BAUDETTE, Minn., Nov. 6, 2019 /PRNewswire/ --For the third quarter 2019:Net revenues of $51.3 million, an increase of 1% versus prior year  GAAP net income of $3.9 million and diluted GAAP earnings per share of $0.32